Tenet Healthcare Co. (NYSE: THC) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $195.00 price target on the stock.
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term [Yahoo! Finance]
Commure to Deploy Ambient AI Platform to Tenet Physician Resources for Enhanced Clinical Workflows
Watch Live: Detroit Mayor Mike Duggan expected to announce political future [CBS News]
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Barclays PLC from $171.00 to $190.00. They now have an "overweight" rating on the stock.